Business Context and Reporting Period
This Form 8-K is filed by Fluidigm Corporation (not Standard BioTools Inc., as indicated in the metadata request) on April 14, 2020. The report addresses preliminary financial results for the quarter ended March 31, 2020, and significant operational updates related to the novel coronavirus pandemic.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the press release furnished as Exhibit 99.1, which is not included in the provided text.
Material Changes and Guidance
- Guidance Withdrawal: The Company announced the withdrawal of its full-year 2020 financial guidance.
- Reason for Change: The withdrawal is due to uncertainty surrounding the ongoing and evolving novel coronavirus pandemic.
- Results Announcement: Preliminary results for the quarter ended March 31, 2020, were issued via press release on April 14, 2020.
Management Commentary and Risks
Management highlighted the novel coronavirus pandemic as a primary risk factor creating significant uncertainty, necessitating the withdrawal of forward-looking guidance. The filing explicitly states that the information furnished, including the press release, is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into future filings unless expressly stated.
Investor Verification Checklist
- Verify the specific preliminary revenue and net loss figures for Q1 2020 in the attached Exhibit 99.1 press release.
- Confirm the current cash position and liquidity runway given the withdrawal of full-year guidance.
- Review the detailed impact of the pandemic on the company's supply chain and customer demand as described in the full press release.
- Note the discrepancy between the metadata company name (Standard BioTools) and the filing registrant (Fluidigm Corporation).